SOUTH PLAINFIELD, N.J. (AP) _ PTC Therapeutics Inc. (PTCT) on Tuesday reported a loss of $60 million in its third quarter.
The South Plainfield, New Jersey-based company said it had a loss of $1.06 per share. Losses, adjusted for non-recurring costs, came to 89 cents per share.
The biopharmaceutical company posted revenue of $71.4 million in the period.
PTC Therapeutics shares have increased 15% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $39.31, an increase of slightly more than 8% in the last 12 months.